Firefly Neuroscience vs Mobile-health Network Solutions
Mobile-health Network Solutions is the larger business, with $7.7m of revenue in fiscal 2026 against $1.1m for Firefly Neuroscience (6.8 times as much). Firefly Neuroscience grew faster (957.4% against 1.2%). Mobile-health Network Solutions kept more of each dollar of sales as profit: a net margin of -41.2% against -1741.0%. Firefly Neuroscience carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Firefly NeuroscienceAIFF, 2025 | Mobile-health Network SolutionsMNDR, 2026 |
|---|---|---|
| Revenue | $1.1m | $7.7m |
| Revenue growth | 957.4% | 1.2% |
| Net income | −$19.9m | −$3.2m |
| Operating margin | -775.5% | — |
| Net margin | -1741.0% | -41.2% |
| Return on equity | — | -51.0% |
| Free cash flow | −$8.2m | −$1.5m |
| Cash | $2.7m | $2.5m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 17 | — |
| Market value | $15.7m | $566,361 |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |